Core A Publication - Archive

Archive papers (2005-2010 Project Period) 

Buchholz, B.A., Haack, K.W., Sporty, J.L., Buckpitt, A.R., and Morin, D. (2010). Free flow electrophoresis separation and AMS quantitation of C-naphthalene-protein adducts. Nucl Instrum Methods Phys Res B 268, 1324-1327.  (Project 4, Core B) PMCID 2864045

Buchholz, B.A., Zermeño P., H.M., Young, T.M., Guilderson T. P. “Measuring Sub-micron Size Fractionated Particulate Matter on Aluminum Impactor Disks” Radiocarbon, 2010, 52(2-3): 278-275.  (Project 1)  NIHMSID #268013.  

Ai, D., W. Pang, N. Li, M. Xu, P.D. Jones, J. Yang, Y. Zhang, N. Chiamvimonvat, J.Y-J. Shyy, B.D. Hammock and Y. Zhu.  2009.  Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.  Proc. Natl. Acad. Sci. USA 106(2):564-569. PMCID: 2626743

Kim, H-J., K. Ahn, A. González-Techera, G.G. Gonzáles-Sapienza, S.J. Gee and B.D. Hammock. 2009. Magnetic bead-based phage anti-immunocomplex assay (PHAIA) for the detection of the urinary biomarker 3-phenoxybenzoic acid to assess human exposure to pyrethroid insecticides.  Anal Biochem. 386(1):45-52. (Project 3)  NIHMS194833 

Liu, J-Y., H-J. Tsai, S.H. Hwang, P.D. Jones, C. Morisseau and B.D. Hammock.  2009.  Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation.  British Journal of Pharmacology 156(2): 284-296. (Project 5)  PMCID: 2697843 

Kasagami, T., I-H. Kim, H-J. Tsai, K. Nishi, B.D. Hammock and C. Morisseau.  2009.  Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorganic & Medicinal Chemistry Letters 19:1784-1789.  (Project 5)  PMCID: 2900318

Parrish, A.R., G. Chen, R.C. Burghardt, T. Watanabe, C. Morisseau and B.D. Hammock. 2009.  Attenuation of cisplatin nephrotoxicity by an inhibition of soluble epoxide hydrolase.  Cell. Biol. Toxicol. 25:217-225. (Project 5)  NIHMSID 267526 

Huang, H., H. Tanaka, B.D. Hammock and C. Morisseau. 2009.  Novel and highly sensitive fluorescent assay for leucine aminopeptidases. Analytical Biochemistry 391:11-16.  (Project 5)  PMCID: 2748848 

Luria, A., C. Morisseau, H-J. Tsai, J. Yang, B. Inceoglu, B.D. Taeye, S.M. Watkins, M.M. Wiest, J.B. German and B.D. Hammock. 2009.  Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase. Am. J. Physiol. Endocrinol. Metab. 297:E375-E383.  (Project 5) PMCID: 2724109 

Liu, J-Y., S-H. Park, C. Morisseau, S.H. Hwang, B.D. Hammock and R.H. Weiss. 2009.  Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo.  Mol. Cancer Ther. 8(8):2193-2203. (Project 5)  PMCID: 2728155 

Ma, Z.Y., D. Dosev, M. Nichkova, S.J. Gee, B.D. Hammock and I.M. Kennedy.  2009.  Synthesis and bio-functionalization of multifunctional magnetic Fe₃O₄@Y₂O₃:Eu nanocomposites.  Journal of Materials Chemistry 19:4695-4700. (Projects 2 and 3)  PMCID: PMC2847302  (Projects 3 and 8)

Nichkova, M., X. Fu, Z. Yang, P. Zhong, J.R. Sanborn, D. Chang, S.J. Gee and B.D. Hammock.  2009.  Immunochemical screening of pesticides (simazine and cypermethrin) in orange oil. J. Agric. Food Chem. 57(13):5673-5679.  (Project 3)  NIHMSID 267615

Falck, J.R., R. Kodela, R. Manne, K.R. Atcha, N. Puli, N. Dubasi, V.L. Manthati, J.H. Capdeliva, X-Y. Yi, D.H. Goldman, C. Morisseau, B.D. Hammock and W.B. Campbell. 2009.  14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: Influence upon vascular relaxation and soluble epoxide hydrolase inhibition. J. Med. Chem. 52:5069-5075. (Project 5)  PMCID: 2888647

Shen, S., F. Zhang, S. Zeng, Y. Tian, X. Chai, S. Gee, B.D. Hammock and J. Zheng.  2009.  Development of enantioselective polyclonal antibodies to detect styrene oxide protein adducts.   Anal. Chem. 81(7):2668-2677.  (Project 3)  NIHMS98521 

Matveeva, E.G., C. Morisseau, M.H. Goodrow, C. Mullin and B.D. Hammock.  2009.  Tryptophan fluorescence quenching by enzyme inhibitors as a tool for enzyme active site structure investigation: epoxide hydrolase.  Current Pharmaceutical Biotechnology 10:589-599.  (Project 5)  PMCID: 2861369 

Yang, J., K. Schmelzer, K. Georgi and B.D. Hammock. 2009.  Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Chem. 81(19):8085-8093. NIHMS142841

Ahn, K.C., S.J. Gee, H-J. Tsai, D. Bennett, M.G. Nishioka, A. Blum, E. Fishman and B.D. Hammock. 2009.  Immunoassay for monitoring environmental and human exposure to the polybrominated diphenyl ether BDE-47.  Environ. Sci. Technol. 43(20):7784-7790.  (Project 3)  NIHMS146249

Barbosa-Sicard, E., T. Frömel, B. Keserü, R.P. Brandes, C. Morisseau, B.D. Hammock, T. Braun, M. Krüger and I. Fleming. 2009.  Inhibition of the soluble epoxide hydrolase by tyrosine nitration. J. Biol. Chem. 284(41):28156-28163.  (Project 5)  PMCID: 2788866 

Lu, C., R. Schoenfeld, Y. Shan, H-J. Tsai, B. Hammock and G. Cortopassi. 2009.  Frataxin deficiency induces schwann cell inflammation and death. Biochimica et Biophysica Acta 1792(11):1052-1061. NIHMS: 138716

Li, N., J-Y. Liu, V. Timofeyev, H. Qiu, S.H. Hwang, D. Tuteja, L. Lu, J. Yang, H. Mochida, R. Low, B.D. Hammock and N. Chiamvimonvat. 2009.  Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches. Journal of Molecular and Cellular Cardiology 47(6):835-845. NIHMS: 147742 

Morisseau, C., O. Merzlikin, A. Lin, G. He, W. Feng, I. Padilla, M.S. Denison, I.N. Pessah and B.D. Hammock. 2009.  Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors. Environmental Health Perspectives 117(12):1867-1872. (Project 5)  PMCID: 2799460 

Chawengsub, Y., K.M. Gauthier, K. Nithipatikom, B.D. Hammock, J.R. Falck, D. Narsimhaswamy and W.B. Campbell. 2009. Identification of 13-hydroxy-14, 15-epoxyeicosatrienoic acid as an acid-stable endothelium-derived hyperpolarizing factor in rabbit arteries. J. Biol. Chem. 284(45):31280-31290. PMCID: 2781526 

Hall, L.M., M.G. Kimlin, P.A. Aronov, B.D. Hammock, J.R. Slusser, L.R. Woodhouse and C.B. Stephensen. 2010.  Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J. Nutr. 140(3):542-550. PMCID: PMC2821886 

Certíková Chábová, V., A. Walkowska, E. Kompanowska-Jezierska, J. Sadowski, P. Kujal, Z. Vernerová, Z. Vanourková, L. Kopkan, H.J. Kramer, J.R. Falck, J.D. Imig, B.D. Hammock, I Vanecková and L. Cervenka. 2010. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. Clinical Science 118(10):617-632. PMCID: 2854172 

Liu, J-Y., J. Yang, B. Inceoglu, H. Qiu, A. Ulu, S-H. Hwang, N. Chiamvimonvat and B.D. Hammock. 2010. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. Biochemical Pharmacology 79(6):880-887. NIHMSID 158074 

Kim, H-J., M.A. Rossotti, K.C. Ahn, G.G. González-Sapienza, S.J. Gee, R. Musker and B.D. Hammock. 2010. Development of a noncompetitive phage anti-immunocomplex assay for brominated diphenyl ether 47. Analytical Biochemistry 401:38-46  (Project 3)  PMCID: PMC2861364

Alihosseini, F., J. Lango, K-S. Ju, B.D. Hammock and G. Sun. 2009. Mutation of bacterium Vibrio gazogenes for selective preparation of colorants. Biotechnol. Prog. 26(2):352-360. NIHMS195955

Carlomagno, M., C. Mathó, G. Cantou, J.R. Sanborn, J.A. Last, B.D. Hammock, A. Roel, D. González and G. González-Sapienza. 2010. A clomazone immunoassay to study the environmental fate of the herbicide in rice (Oryza sativa) agriculture. J. Agric. Food Chem. 58(7):4367-4371. (Project 3)  NIHMS189902 

García-Nieto, E., M. Nichkova, L. Yáñez, R. Costilla-Salazar, A. Torres-Dosal, S.J. Gee, B.D. Hammock, L. Juárez-Santacruz and F. Díaz-Barriga. 2010.  Assessment of dioxin-like soil contamination in Mexico by enzyme-linked immunosorbent assay. Arch. Environ. Contam. Toxicol. 58(4):918-926. PMID: 20091164  (Project 3)  NIHMSID 267618

Tsai, H-J., S.H. Hwang, C. Morisseau, J. Yang,  P.D. Jones, T. Kasagami, I-H. Kim and B.D. Hammock. 2010.  Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.  Eur. J. Pharm. Sci. 40(3):222-238.  (Project 5)  NIHMS: 203825 

Nording, M.L., J. Yang, C.M. Hegedus, A. Bhushan, N.J. Kenyon, C.E. Davis and B.D. Hammock. 2010.  Endogenous levels of five fatty acid metabolites in exhaled breath condensate to monitor asthma by high-performance liquid chromatography: electrospray tandem mass spectrometry. IEEE Sensors Journal 10(1):123-130  PMCID 2981865

Liu, J-Y., N. Li, J. Yang, N. Li, H. Qiu, D. Ai, N. Chiamvimonvat, Y. Zhu and B.D. Hammock. 2010. Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc. Natl. Acad. Sci. USA 107(39):17017-17022.  PMCID: 2947894

Rayo, J., L. Muñoz, G. Rosell, B.D. Hammock, A. Guerrero, F.J. Luque and R. Pouplana. 2010. Reactivity versus steric effects in flourniated ketones as esterase inhibitors: a quantum mechanical and molecular dynamics study. J. Mol. Model. 16(11):1753-1764. PMCID: 3014912

Rose, T.E., C. Morisseau, J-Y. Liu, B. Inceoglu, P.D. Jones, J.R. Sanborn and B.D. Hammock. 2010. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure – activity relationships, pharmacokinetics, and reduction of inflammatory pain. J. Med. Chem. 53(19):7067-7075. (Project 5)   NIHMS233914

Morisseau, C., B. Inceoglu, K. Schmelzer, H-J. Tsai, S.L. Jinks, C.M. Hegedus and B.D. Hammock. 2010. Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J. Lipid Res. 51(12):3481-3490.  (Project 5)  PMCID: 2975720 

Baumann, A., W. Lohmann, T. Rose, K.C. Ahn, B.D. Hammock, U. Karst and N.H. Schebb. 2010. Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolites. Drug Metab. Dispos. 38(12): 2130-2138  PMCID: PMC2993458

Rossotti, M.A., M. Carlomagno, A. González-Techera, B.D. Hammock, J. Last and G. González-Sapienza. 2010. Phage anti-immunocomplex assay for clomazone: Two-site recognition increasing assay specificity and facilitating adaptation into an on-site format. Anal. Chem. 82(21):8838-8843.  (Project 3)  NIHMS242038 

*Collaborative publications in bold

Recent papers from 2011-2015 Project Period